Skip to main content
All lobbying clients

PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA)

Lobbying client · Virginia · filed 2025 to 2026

An association comprised of pharmaceutical companies and labor unions

$490,000 Reported spend
20 Filings counted
3 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 20 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $210,000 8 filings
  • 2025 $280,000 12 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
 Recent filings 20 total
Q3 report
NELSON MULLINS RILEY & SCARBOROUGH
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2026
View → Q3 report
THE HARPLE GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 14, 2026
View → Q2 report
NELSON MULLINS RILEY & SCARBOROUGH
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View → Q2 report
THE HARPLE GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 10, 2026
View → Q2 terminationNo activity
DENTONS US LLP
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 6, 2026
View → Q1 report
NELSON MULLINS RILEY & SCARBOROUGH
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 20, 2026
View → Q1 report
THE HARPLE GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 14, 2026
View → Q1 reportNo activity
DENTONS US LLP
1st Quarter 2026 (Jan 1 - Mar 31) · posted Mar 24, 2026
View → Q4 report
NELSON MULLINS RILEY & SCARBOROUGH
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 20, 2026
View → Q4 report
THE HARPLE GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 15, 2026
View → Q4 reportNo activity
DENTONS US LLP
4th Quarter 2025 (Oct 1 - Dec 31) · posted Jan 8, 2026
View → Q3 report
NELSON MULLINS RILEY & SCARBOROUGH
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 20, 2025
View → Q3 report
THE HARPLE GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 9, 2025
View → Q3 reportNo activity
DENTONS US LLP
3rd Quarter 2025 (July 1 - Sep 30) · posted Sep 24, 2025
View → Q2 report
NELSON MULLINS RILEY & SCARBOROUGH
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 21, 2025
View → Q2 reportNo activity
DENTONS US LLP
2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 17, 2025
View → Q2 report
THE HARPLE GROUP, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $30,000 income · posted Jul 15, 2025
View → Q1 report
NELSON MULLINS RILEY & SCARBOROUGH
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 17, 2025
View → Q1 report
THE HARPLE GROUP, LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $30,000 income · posted Apr 17, 2025
View → Q1 reportNo activity
DENTONS US LLP
1st Quarter 2025 (Jan 1 - Mar 31) · posted Apr 14, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem